SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 190,579.34 |
Enterprise Value ($M) | 209,318.34 |
Book Value ($M) | 59,423.00 |
Book Value / Share | 26.09 |
Price / Book | 3.21 |
NCAV ($M) | -21,120.00 |
NCAV / Share | -9.27 |
Price / NCAV | -9.02 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.08 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | 0.10 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.04 |
Current Ratio | 1.29 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 36,910.00 |
Assets | 117,453.00 |
Liabilities | 58,030.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 51,828.00 |
Operating Income | 12,859.00 |
Net Income | 6,955.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 14,236.00 |
Cash from Investing | 1,468.00 |
Cash from Financing | -20,562.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock Inc. | 5.40 | -5.12 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
160,991 | 1,755,634 | 9.17 | |
245,660 | 2,546,169 | 9.65 | |
224,525 | 2,248,614 | 9.99 | |
181,136 | 2,119,525 | 8.55 | |
(click for more detail) |
Similar Companies | |
---|---|
MYOV – Myovant Sciences Ltd. | NUVB – Nuvation Bio Inc |
NVO – Novo-Nordisk A/S | OGN – Organon & Co. |
PBH – Prestige Brands Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io